Background Fatty liver is associated with insulin resistance, dyslipidemia, and obesity and is
therefore considered a phenotype of metabolic syndrome. However, less is known regarding …

METHODS: The subjects of this study were 293 patients who had undergone abdominal
computed tomography (CT) and sonography. Fatty pancreas was diagnosed by sonographic …

Fat accumulation in the pancreas associated with obesity and the metabolic syndrome
(MetS) has been defined as “non-alcoholic fatty pancreas disease”(NAFPD). The aim of this …

Background Fatty infiltration of the pancreas is an enigmatic manifestation of ectopic fat
deposition in obesity. Studies have shown that pancreatic lipid accumulation interferes with …

Background and Objective: Fat accumulation in the pancreas has remained a relatively
unknown disease since it was initially described in 1926. However, it has gained increasing …

Background Fatty infiltration of the pancreas has been shown to interfere with insulin
secretion. Both insulin sensitivity and secretion are important in the pathogenesis of …

Objectives Pancreas steatosis is the description of fat accumulation in the pancreatic gland.
The prevalence and development mechanisms of pancreatic steatosis in patients with …

Objectives: Obesity and insulin resistance cause fatty infiltration of many organs, including
the pancreas (pancreatic steatosis [PS]) and the liver (nonalcoholic fatty liver disease …

There is an epidemic of obesity worldwide. The prevalence of obesity has doubled over the
last three decades. Obesity, especially abdominal obesity is associated with insulin …

Background The clinical significance of non-alcoholic fatty pancreatic disease (NAFPD) or
fatty pancreas is largely unknown. It is often an incidental finding on abdominal ultrasound …